Filing Details

Accession Number:
0000937556-18-000057
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-02 21:09:00
Reporting Period:
2018-03-29
Accepted Time:
2018-04-02 21:09:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
937556 Masimo Corp MASI Electromedical & Electrotherapeutic Apparatus (3845) 330368882
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1442689 Jon Coleman C/O Masimo Corporation
52 Discovery
Irvine CA 92618
Pres-Ww Sales,Pro Svc,Med Affs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-03-29 11,303 $24.68 20,504 No 4 M Direct
Common Stock Disposition 2018-03-29 11,303 $87.50 9,201 No 4 S Direct
Common Stock Acquisiton 2018-03-29 6,000 $21.97 15,201 No 4 M Direct
Common Stock Disposition 2018-03-29 6,000 $87.50 9,201 No 4 S Direct
Common Stock Acquisiton 2018-03-29 12,000 $28.03 21,201 No 4 M Direct
Common Stock Disposition 2018-03-29 12,000 $87.50 9,201 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2018-03-29 11,303 $24.68 11,303 $24.68
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2018-03-29 6,000 $21.97 6,000 $21.97
Common Stock Non-Qualified Stock Option (Right to Buy) Disposition 2018-03-29 12,000 $28.03 12,000 $28.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-08-17 2019-08-17 No 4 M Direct
6,000 2014-05-28 2023-05-28 No 4 M Direct
6,000 2015-02-18 2024-02-18 No 4 M Direct
Footnotes
  1. The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated March 9, 2018, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
  2. This option was granted on August 17, 2009 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
  3. This option was granted on May 28, 2013 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
  4. This option was granted on February 18, 2014 and is exercisable as the option vests. The option vests over a 5 year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.